CINCINNATI, Dec. 9 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL) a leading, global full-service clinical research organization, today announced President Simon Higginbotham will participate in the annual Raymond James Boston Fall Investors Conference. The conference will be held at The State Room, 60 State Street, 33rd floor, in Boston on Dec. 11, 2008. Kendle's presentation is scheduled from 2:30 to 3:15 p.m. Eastern Standard Time.
Presentations will not be webcast at the conference. However, slides from Kendle's presentation will be available by 11 a.m. Eastern Standard Time on Dec. 11 at http://www.kendle.com under the Investor Events and Presentations section.
Kendle International Inc. (Nasdaq: KNDL) is a leading global clinical research organization providing the full range of early- to late-stage clinical development services for the world's biopharmaceutical industry. Our focus is on innovative solutions that reduce cycle times for our customers and accelerate the delivery of life-enhancing drugs to market for the benefit of patients worldwide. As one of the fastest-growing global providers of Phase I-IV services, we offer experience spanning 90 countries, along with industry-leading patient access and retention capabilities and broad therapeutic expertise, to meet our customers' clinical development challenges.
Kendle was recognized by FORTUNE magazine as one of the 100
fastest-growing companies in the United States for 2008. The company also has
been recognized as "T
|SOURCE Kendle International Inc.|
Copyright©2008 PR Newswire.
All rights reserved